Evidence map›Paper›PMID 42778552›Full record

ArticleNature communications2026

Predicting acute and chronic diabetes complications among adults newly diagnosed with diabetes: development and validation of dynamic risk prediction models.

Rozalina G McCoy, Shrinath Patel, Louis Faust, Herbert C Heien, Nan Zhang, Brian Caffo, Che Ngufor

Abstract readValidation Study
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rozalina G McCoyDivision of Endocrinology, Diabetes, & Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. Rozalina.McCoy@som.umaryland.edu.ORCID http://orcid.org/0000-0002-2289-3183
Shrinath PatelMayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.
Louis FaustMayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.
Herbert C HeienOptum Labs, Eden Prairie, MN, USA.
Nan ZhangMayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.
Brian CaffoJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Che NguforMayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

Funding

Program Development (Pilot) Core (Core B)P30AG097158 · NIA · UNIV OF MARYLAND, COLLEGE PARK · PI Stephen B. Thomas · 2025 to 2026
$1.3M
Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with DiabetesK23DK114497 · NIDDK · MAYO CLINIC ROCHESTER · PI MCCOY, ROZALINA GRUBINA · 2017 to 2021
$846k
NIA NIH HHS P30 AG097158NIDDK NIH HHS K23 DK114497U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) K23DK114497U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P30AG097158
6 · The paper itself

Abstract

Diabetes affects one in ten adults worldwide, yet clinicians lack tools to simultaneously predict which complications a given patient is most likely to develop in the near term. Existing risk models typically address single complications, were developed in specialized cohorts, and use heterogeneous time horizons, limiting their utility for individualized clinical decision-making. Here, we show that machine learning models trained on nationwide U.S. administrative claims data for 400,400 adults with newly diagnosed type 1 or type 2 diabetes can accurately predict the monthly risk of nine acute and chronic complications (cardiovascular disease, cerebrovascular disease, peripheral vascular disease, nephropathy, neuropathy, retinopathy, and hypoglycemic and hyperglycemic crises) with predictions that update dynamically as new clinical data become available. Using Regularized Logistic Regression (GLMnet) and Extreme Gradient Boosting (XGBoost) with walk-forward temporal validation, we demonstrate strong discrimination in external validation against an independent electronic health record cohort (areas under the receiver operating characteristic curve 0.77-0.85 across complications for the best-performing model). The Diabetes Complications Risk Calculator therefore provides encounter-specific near-term risk estimates for multiple diabetes complications using routinely available clinical data, offering a potential framework for personalized risk stratification that could support shared decision-making and population health management across healthcare settings. The generalizability of the Diabetes Complications Risk Calculator to other cohorts will need to be tested.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdultAgedBoosting Machine Learning AlgorithmsChronic DiseaseFemaleHumansLogistic ModelsMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRisk AssessmentRisk Factors

Identifiers

PMID42778552
PMCPMC13601617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.